Successful Monitoring of Fluoxetine-Induced Nocturnal Bruxism

Iskandar, Joseph W.; Wood, Brian E.; Ali, Rizwan; Wood, Rebecca L.

doi:10.4088/jcp.11cr07321

Cited by 8 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[11][12][13] One case reported spontaneous resolution of symptoms without any interventions. 14 In the above articles, buspirone dosage typically ranged between 5 and 30 mg administered in 1-3 doses per day.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

SSRI-associated bruxism

Garrett

Hawley

2018

Neur Clin Pract

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

“…The case of spontaneous symptom resolution without intervention, as mentioned, reported resolution after 4 weeks. 14…”

Section: Resultsmentioning

confidence: 99%

SSRI-associated bruxism

Garrett

Hawley

2018

Neur Clin Pract

View full text Add to dashboard Cite

show abstract

“…Effective treatment of social phobia SP may mitigate bruxism [19]. A study documents the successful monitoring of uoxetine-induced nocturnal bruxism in a healthy adult without a change in the patient's medication regimen [20].…”

Section: Gabapentinmentioning

confidence: 99%

Buspirone effectiveness in treating SSRI related Bruxism, a comprehensive systematic review

Zarzar¹,

Khalifa

2022

Preprint

View full text Add to dashboard Cite

The aim of this paper is to do a systematic review using the PRISMA flow system investigating Buspirone’s role in the treatment of bruxism induced by the psychoactive family of selective serotonin reuptake inhibitors, SSRIs. We did a comparison between patients with bruxism who received intervention by Buspirone and the controls of Buspirone intervention in a review. We included research articles, case reports and full text articles. We also excluded systematic and literature reviews for the purpose of having specific data about the topic. The databases were Pubmed and Google scholar.

show abstract

“…Regarding the clinical management, some authors have suggested to “wait and see” for 1 month because spontaneous remission may occur [ 62 ]. If the problem persists, a reduction of dose or change of medication may alleviate or even resolve the problem [ 57 – 59 , 73 , 79 ], although a definitive cease might be expected with drug withdrawal [ 58 , 63 , 66 , 72 , 74 , 75 , 79 , 81 ].…”

Section: Bruxism As An Adverse Effect Of Medicationsmentioning

confidence: 99%

Current Treatments of Bruxism

Guaita

Högl

2016

Curr Treat Options Neurol

View full text Add to dashboard Cite

Opinion statementDespite numerous case reports, the evidence for treatment of bruxism is still low. Different treatment modalities (behavioral techniques, intraoral devices, medications, and contingent electrical stimulation) have been applied. A clinical evaluation is needed to differentiate between awake bruxism and sleep bruxism and rule out any medical disorder or medication that could be behind its appearance (secondary bruxism). A polysomnography is required only in a few cases of sleep bruxism, mostly when sleep comorbidities are present. Counselling with regard to sleep hygiene, sleep habit modification, and relaxation techniques has been suggested as the first step in the therapeutic intervention, and is generally considered not harmful, despite low evidence of any efficacy. Occlusal splints are successful in the prevention of dental damage and grinding sounds associated with sleep bruxism, but their effects on reducing bruxism electromyographic (EMG) events are transient. In patients with psychiatric and sleep comorbidities, the acute use of clonazepam at night has been reported to improve sleep bruxism, but in the absence of double-blind randomized trials, its use in general clinical practice cannot be recommended. Severe secondary bruxism interfering with speaking, chewing, or swallowing has been reported in patients with neurological disorders such as in cranial dystonia; in these patients, injections of botulinum toxin in the masticatory muscles may decrease bruxism for up to 1–5 months and improve pain and mandibular functions. Long-term studies in larger and better specified samples of patients with bruxism, comparing the effects of different therapeutic modalities on bruxism EMG activity, progression of dental wear, and orofacial pain are current gaps of knowledge and preclude the development of severity-based treatment guidelines.

show abstract

Successful Monitoring of Fluoxetine-Induced Nocturnal Bruxism

Cited by 8 publications

References 0 publications

SSRI-associated bruxism

SSRI-associated bruxism

Buspirone effectiveness in treating SSRI related Bruxism, a comprehensive systematic review

Current Treatments of Bruxism

Contact Info

Product

Resources

About